Please try another search
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; other infectious disease vaccines for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
Name | Age | Since | Title |
---|---|---|---|
Valerie Montgomery Rice | - | - | Director & Special Advisor to the Chairman and CEO |
David Alan Dodd | 74 | 2010 | Chairman, President & CEO |
Harriet Latham Robinson | 86 | 2001 | Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board |
Dean G. Kollintzas | 51 | 2006 | Independent Director |
Barney S. Graham | - | - | Member of Scientific Advisory Board |
Stanley A. Plotkin | 91 | - | Member of Scientific Advisory Board |
John N. Spencer | 83 | 2006 | Independent Director |
Robert T. McNally | 76 | 2006 | Independent Director |
Scott C. Weaver | - | - | Member of Scientific Advisory Board |
Olivera J. Finn | - | - | Member of Scientific Advisory Board |
Randal D. Chase | 74 | 2015 | Independent Director |
Nicole Lemerond | 48 | 2022 | Independent Director |
Jayne Morgan | 60 | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review